DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT:NAVB) (“Navidea” or the “Company”) announced today that it will be filing a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission (the “SEC”), extending the deadline to file its Form 10-K for the fiscal year ended December 31, 2015 to March 30, 2016 (the “Fiscal Year 2015 Form 10-K”).
